* USANA Health Sciences Inc USNA.N reported quarterly
adjusted
earnings of 95 cents per share for the quarter ended in March.
The lone analyst forecast for the quarter was for earnings of 77
cents per share.
* Revenue fell 9% to $248.36 million from a year ago;
analysts
expected $240.22 million.
* USANA Health Sciences Inc's reported EPS for the quarter
was 95
cents.
* The mean earnings estimate of analysts had fallen by
about 13%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* USANA Health Sciences Inc shares had risen by 2.9% this
quarter and gained 21.7% so far this year.
* The company reported quarterly net income of $18.38
million.
* Wall Street's median 12-month price target for USANA
Health
Sciences Inc is $52.50
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
April 25 at 10:05 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 0.77 0.95 Beat
Dec. 31 2022 0.35 0.66 Beat
Sep. 30 2022 0.89 0.78 Missed
Jun. 30 2022 1.14 1.00 Missed